The F.D.A. approved an artificial vessel to restore blood flow in patients, despite its own scientists flagging questionable study results and potentially fatal ruptures of the product.
Related Posts
Markets Slump on Persistent Concern That Tariffs Will Hurt Growth
Trump’s tariffs continued to jar investors on Monday as stocks in Asia mostly fell and the U.S. dollar weakened.
Telegraph Newspaper to Be Sold to Private Equity Firm RedBird Capital
After years in limbo, the British newspaper is set to be bought by RedBird Capital, an American investment firm with many sports, media and entertainment […]
Henry Raymont, First to Report Bay of Pigs Invasion, Dies at 98
On assignment for U.P.I. in Cuba, he learned of the U.S.- backed effort to overthrow Fidel Castro and was imprisoned. He later worked for The […]